Home › Pulmonary Arterial Hypertension › Tennessee › Nashville
Pulmonary Arterial Hypertension clinical trials in Nashville, TN
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Hormonal, Metabolic, and Signaling Interactions in PAH
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Recruiting
- Vanderbilt University Medical Center, Nashville
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
Mobile Health Intervention to Improve Exercise in Pediatric PH
Recruiting
- Vanderbilt University Medical Center, Nashville
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Vanderbilt Children's Hospital, Nashville
- Vanderbilt University Medical Center, Nashville
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Mountain View, CA7 studies
- Cincinnati, OH7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Houston, TX4 studies
- Dallas, TX4 studies
- Louisville, KY4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.